PDF herunterladen
Semin Thromb Hemost 2015; 41(07): 737-746
DOI: 10.1055/s-0035-1564041
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Role of Tissue Factor in Atherothrombosis and Coronary Artery Disease: Insights into Platelet Tissue Factor

Marina Camera
1   Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
2   Centro Cardiologico Monzino IRCCS, Milan, Italy
,
Vincenzo Toschi
3   Division of Haematology and Blood Transfusion and Thrombosis Centre, AO Ospedale San Carlo Borromeo, Milan, Italy
,
Marta Brambilla
2   Centro Cardiologico Monzino IRCCS, Milan, Italy
,
Maddalena Lettino
4   Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy
,
Laura Rossetti
2   Centro Cardiologico Monzino IRCCS, Milan, Italy
,
Paola Canzano
2   Centro Cardiologico Monzino IRCCS, Milan, Italy
,
Alessandro Di Minno
1   Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
2   Centro Cardiologico Monzino IRCCS, Milan, Italy
,
Elena Tremoli
1   Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy
2   Centro Cardiologico Monzino IRCCS, Milan, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
26. September 2015 (online)

    Lizenzen und Reprints

Abstract

The contribution of vessel wall-derived tissue factor (TF) to atherothrombosis is well established, whereas the pathophysiological relevance of the blood-borne TF is still a matter of debate, and controversies on the presence of platelet-associated TF still exist. In the past 15 years, several studies have documented the presence of TF in human platelets, the capacity of human platelets to use TF mRNA to make de novo protein synthesis, and the increase in the percentage of TF positive platelets in pathological conditions such as coronary artery disease (CAD). The exposure of vessel wall-derived TF at the site of vascular injury would play its main role in the initiation phase, whereas the blood-borne TF carried by platelets would be involved in the propagation phase of thrombus formation. More recent data indicate that megakaryocytes are committed to release into the bloodstream a well-defined number of TF-carrying platelets, which represents only a fraction of the whole platelet population. These findings are in line with the evidence that platelets are heterogeneous in their functions and only a subset of them is involved in the hemostatic process. In this review we summarize the existing knowledge on platelet associated TF and speculate on its relevance to physiology and to atherothrombosis and CAD.

Keywords

tissue factor - platelets - megakaryocytes - atherothrombosis - coronary artery disease
 

  • References

  • 1 Fisher KL, Gorman CM, Vehar GA, O'Brien DP, Lawn RM. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48 (1) 89-99
    CrossrefPubMedGoogle Scholar
  • 2 Scarpati EM, Wen D, Broze Jr GJ , et al. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26 (17) 5234-5238
    CrossrefPubMedGoogle Scholar
  • 3 Morrissey JH, Fakhrai H, Edgington TS. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50 (1) 129-135
    CrossrefPubMedGoogle Scholar
  • 4 Spicer EK, Horton R, Bloem L , et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci U S A 1987; 84 (15) 5148-5152
    CrossrefPubMedGoogle Scholar
  • 5 Giesen PL, Rauch U, Bohrmann B , et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A 1999; 96 (5) 2311-2315
    CrossrefPubMedGoogle Scholar
  • 6 Rauch U, Nemerson Y. Circulating tissue factor and thrombosis. Curr Opin Hematol 2000; 7 (5) 273-277
    CrossrefPubMedGoogle Scholar
  • 7 Tremoli E, Camera M, Toschi V, Colli S. Tissue factor in atherosclerosis. Atherosclerosis 1999; 144 (2) 273-283
    CrossrefPubMedGoogle Scholar
  • 8 van der Wal AC, Li X, de Boer OJ. Tissue factor expression in the morphologic spectrum of vulnerable atherosclerotic plaques. Semin Thromb Hemost 2006; 32 (1) 40-47
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Taubman MB, Fallon JT, Schecter AD , et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997; 78 (1) 200-204
    PubMedGoogle Scholar
  • 10 Asada Y, Marutsuka K, Hatakeyama K , et al. The role of tissue factor in the pathogenesis of thrombosis and atherosclerosis. J Atheroscler Thromb 1998; 4 (3) 135-139
    CrossrefPubMedGoogle Scholar
  • 11 Moons AH, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res 2002; 53 (2) 313-325
    CrossrefPubMedGoogle Scholar
  • 12 Owens III AP, Mackman N. Role of tissue factor in atherothrombosis. Curr Atheroscler Rep 2012; 14 (5) 394-401
    CrossrefPubMedGoogle Scholar
  • 13 Bouchard BA, Mann KG, Butenas S. No evidence for tissue factor on platelets. Blood 2010; 116 (5) 854-855
    CrossrefPubMedGoogle Scholar
  • 14 Camera M, Brambilla M, Toschi V, Tremoli E. Tissue factor expression on platelets is a dynamic event. Blood 2010; 116 (23) 5076-5077
    CrossrefPubMedGoogle Scholar
  • 15 Camera M, Brambilla M, Boselli D , et al. Functionally active platelets do express tissue factor. Blood 2012; 119 (18) 4339-4341
    CrossrefPubMedGoogle Scholar
  • 16 Østerud B, Olsen JO. Human platelets do not express tissue factor. Thromb Res 2013; 132 (1) 112-115
    CrossrefPubMedGoogle Scholar
  • 17 Østerud B. Tissue factor expression in blood cells. Thromb Res 2010; 125 (Suppl. 01) S31-S34
    CrossrefPubMedGoogle Scholar
  • 18 Fukuda C, Iijima K, Nakamura K. Measuring tissue factor (factor III) activity in plasma. Clin Chem 1989; 35 (9) 1897-1900
    PubMedGoogle Scholar
  • 19 Key NS, Slungaard A, Dandelet L , et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91 (11) 4216-4223
    PubMedGoogle Scholar
  • 20 Albrecht S, Kotzsch M, Siegert G , et al. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 1996; 75 (5) 772-777
    PubMedGoogle Scholar
  • 21 Soejima H, Ogawa H, Yasue H , et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999; 99 (22) 2908-2913
    CrossrefPubMedGoogle Scholar
  • 22 Suefuji H, Ogawa H, Yasue H , et al. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134 (2 Pt 1): 253-259
    CrossrefPubMedGoogle Scholar
  • 23 Misumi K, Ogawa H, Yasue H , et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 1998; 81 (1) 22-26
    CrossrefPubMedGoogle Scholar
  • 24 Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 1998; 26 (12) 2005-2009
    CrossrefPubMedGoogle Scholar
  • 25 Amengual O, Atsumi T, Khamashta MA, Hughes GR. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79 (2) 276-281
    PubMedGoogle Scholar
  • 26 Asakura H, Kamikubo Y, Goto A , et al. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80 (3) 217-224
    CrossrefPubMedGoogle Scholar
  • 27 Carey MJ, Rodgers GM. Disseminated intravascular coagulation: clinical and laboratory aspects. Am J Hematol 1998; 59 (1) 65-73
    CrossrefPubMedGoogle Scholar
  • 28 Hugel B, Socié G, Vu T , et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 1999; 93 (10) 3451-3456
    PubMedGoogle Scholar
  • 29 Jy W, Horstman LL, Arce M, Ahn YS. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992; 119 (4) 334-345
    PubMedGoogle Scholar
  • 30 Warkentin TE, Hayward CP, Boshkov LK , et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84 (11) 3691-3699
    CrossrefPubMedGoogle Scholar
  • 31 Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC , et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96 (10) 3534-3541
    CrossrefPubMedGoogle Scholar
  • 32 Nieuwland R, Berckmans RJ, McGregor S , et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95 (3) 930-935
    PubMedGoogle Scholar
  • 33 Rauch U, Bonderman D, Bohrmann B , et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96 (1) 170-175
    PubMedGoogle Scholar
  • 34 Rauch U, Nemerson Y. Tissue factor, the blood, and the arterial wall. Trends Cardiovasc Med 2000; 10 (4) 139-143
    CrossrefPubMedGoogle Scholar
  • 35 Zillmann A, Luther T, Müller I , et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001; 281 (2) 603-609
    CrossrefPubMedGoogle Scholar
  • 36 Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets 2002; 13 (4) 247-253
    CrossrefPubMedGoogle Scholar
  • 37 Camera M, Frigerio M, Toschi V , et al. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arterioscler Thromb Vasc Biol 2003; 23 (9) 1690-1696
    CrossrefPubMedGoogle Scholar
  • 38 Müller I, Klocke A, Alex M , et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J 2003; 17 (3) 476-478
    PubMedGoogle Scholar
  • 39 Brambilla M, Camera M, Colnago D , et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb Vasc Biol 2008; 28 (5) 947-953
    CrossrefPubMedGoogle Scholar
  • 40 Fink L, Hölschermann H, Kwapiszewska G , et al. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb Haemost 2003; 90 (4) 749-756
    PubMedGoogle Scholar
  • 41 Schwertz H, Tolley ND, Foulks JM , et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 2006; 203 (11) 2433-2440
    CrossrefPubMedGoogle Scholar
  • 42 Panes O, Matus V, Sáez CG, Quiroga T, Pereira J, Mezzano D. Human platelets synthesize and express functional tissue factor. Blood 2007; 109 (12) 5242-5250
    CrossrefPubMedGoogle Scholar
  • 43 Gerrits AJ, Koekman CA, van Haeften TW, Akkerman JW. Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin. Diabetes 2010; 59 (6) 1487-1495
    CrossrefPubMedGoogle Scholar
  • 44 Falanga A, Marchetti M, Vignoli A , et al. V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules. Exp Hematol 2007; 35 (5) 702-711
    CrossrefPubMedGoogle Scholar
  • 45 Tilley RE, Holscher T, Belani R, Nieva J, Mackman N. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 2008; 122 (5) 604-609
    CrossrefPubMedGoogle Scholar
  • 46 Weyrich AS, Dixon DA, Pabla R , et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A 1998; 95 (10) 5556-5561
    CrossrefPubMedGoogle Scholar
  • 47 Lindemann S, Tolley ND, Dixon DA , et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154 (3) 485-490
    CrossrefPubMedGoogle Scholar
  • 48 Evangelista V, Manarini S, Di Santo A , et al. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin. Circ Res 2006; 98 (5) 593-595
    CrossrefPubMedGoogle Scholar
  • 49 Camera M, Brambilla M, Facchinetti L , et al. Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res 2012; 129 (3) 279-284
    CrossrefPubMedGoogle Scholar
  • 50 Brambilla M, Facchinetti L, Canzano P , et al. Human megakaryocytes express Tissue Factor and deliver it to a subset of shedded platelets where it contributes to thrombin generation. Thromb Haemost 2015; 114 (3) 579-592
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 51 Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101 (6) 2285-2293
    CrossrefPubMedGoogle Scholar
  • 52 Bugert P, Dugrillon A, Günaydin A, Eichler H, Klüter H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 2003; 90 (4) 738-748
    PubMedGoogle Scholar
  • 53 Hillmann AG, Harmon S, Park SD, O'brien J, Shields DC, Kenny D. Comparative RNA expression analyses from small-scale, single-donor platelet samples. J Thromb Haemost 2006; 4 (2) 349-356
    CrossrefPubMedGoogle Scholar
  • 54 Muszbek L, Adány R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation, and function. Crit Rev Clin Lab Sci 1996; 33 (5) 357-421
    CrossrefPubMedGoogle Scholar
  • 55 Jayo A, Conde I, Lastres P, Jiménez-Yuste V, González-Manchón C. New insights into the expression and role of platelet factor XIII-A. J Thromb Haemost 2009; 7 (7) 1184-1191
    CrossrefPubMedGoogle Scholar
  • 56 Takenaka T, Kuribayashi K, Tsukiyama M, Nakamine H, Fukuhara Y, Kuno T. Concentration of mRNA for von Willebrand factor in platelets of type I von Willebrand disease. Clin Chim Acta 1996; 245 (1) 125-127
    CrossrefPubMedGoogle Scholar
  • 57 Maroney SA, Haberichter SL, Friese P , et al. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood 2007; 109 (5) 1931-1937
    CrossrefPubMedGoogle Scholar
  • 58 Reitsma PH, Ploos van Amstel HK, Bertina RM. Three novel mutations in five unrelated subjects with hereditary protein S deficiency type I. J Clin Invest 1994; 93 (2) 486-492
    CrossrefPubMedGoogle Scholar
  • 59 Martincic D, Kravtsov V, Gailani D. Factor XI messenger RNA in human platelets. Blood 1999; 94 (10) 3397-3404
    PubMedGoogle Scholar
  • 60 Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22 (9) 1381-1389
    CrossrefPubMedGoogle Scholar
  • 61 Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost 2005; 3 (10) 2185-2192
    CrossrefPubMedGoogle Scholar
  • 62 Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost 2013; 11 (1) 2-16
    PubMedGoogle Scholar
  • 63 van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 2008; 9 (2) 112-124
    CrossrefPubMedGoogle Scholar
  • 64 Lhermusier T, Chap H, Payrastre B. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost 2011; 9 (10) 1883-1891
    CrossrefPubMedGoogle Scholar
  • 65 Zwaal RF, Comfurius P, van Deenen LL. Membrane asymmetry and blood coagulation. Nature 1977; 268 (5618) 358-360
    CrossrefPubMedGoogle Scholar
  • 66 Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010; 468 (7325) 834-838
    CrossrefPubMedGoogle Scholar
  • 67 Bevers EM, Comfurius P, van Rijn JL, Hemker HC, Zwaal RF. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982; 122 (2) 429-436
    CrossrefPubMedGoogle Scholar
  • 68 Bevers EM, Comfurius P, Zwaal RF. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736 (1) 57-66
    CrossrefPubMedGoogle Scholar
  • 69 Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81 (10) 2554-2565
    PubMedGoogle Scholar
  • 70 London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem 2004; 279 (19) 19854-19859
    CrossrefPubMedGoogle Scholar
  • 71 Wolfs JL, Comfurius P, Rasmussen JT , et al. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 2005; 62 (13) 1514-1525
    CrossrefPubMedGoogle Scholar
  • 72 Kalafatis M, Egan JO, van 't Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr 1997; 7 (3) 241-280
    CrossrefPubMedGoogle Scholar
  • 73 Bouchard BA, Williams JL, Meisler NT, Long MW, Tracy PB. Endocytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost 2005; 3 (3) 541-551
    CrossrefPubMedGoogle Scholar
  • 74 Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost 2005; 3 (3) 450-456
    CrossrefPubMedGoogle Scholar
  • 75 Weiss HJ, Lages B, Zheng S, Hayward CP. Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. Am J Hematol 2001; 66 (2) 130-139
    CrossrefPubMedGoogle Scholar
  • 76 Fager AM, Wood JP, Bouchard BA, Feng P, Tracy PB. Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase. Arterioscler Thromb Vasc Biol 2010; 30 (12) 2400-2407
    CrossrefPubMedGoogle Scholar
  • 77 Stalker TJ, Traxler EA, Wu J , et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 2013; 121 (10) 1875-1885
    CrossrefPubMedGoogle Scholar
  • 78 Jorgensen L, Rowsell HC, Hovig T, Mustard JF. Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am J Pathol 1967; 51 (5) 681-719
    PubMedGoogle Scholar
  • 79 Stehbens WE, Biscoe TJ. The ultrastructure of early platelet aggregation in vivo. Am J Pathol 1967; 50 (2) 219-243
    PubMedGoogle Scholar
  • 80 White JG. Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis. Cardiovasc Clin 1987; 18 (1) 13-33
    PubMedGoogle Scholar
  • 81 Palmerini T, Tomasi L, Barozzi C , et al. Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction. PLoS ONE 2013; 8 (12) e81501
    CrossrefPubMedGoogle Scholar
  • 82 Hernández Vera R, Vilahur G, Ferrer-Lorente R, Peña E, Badimon L. Platelets derived from the bone marrow of diabetic animals show dysregulated endoplasmic reticulum stress proteins that contribute to increased thrombosis. Arterioscler Thromb Vasc Biol 2012; 32 (9) 2141-2148
    CrossrefPubMedGoogle Scholar
  • 83 Tyagi T, Ahmad S, Gupta N , et al. Altered expression of platelet proteins and calpain activity mediate hypoxia-induced prothrombotic phenotype. Blood 2014; 123 (8) 1250-1260
    CrossrefPubMedGoogle Scholar
  • 84 Karges HE, Funk KA, Ronneberger H. Activity of coagulation and fibrinolysis parameters in animals. Arzneimittelforschung 1994; 44 (6) 793-797
    PubMedGoogle Scholar
  • 85 Windberger U, Bartholovitsch A, Plasenzotti R, Korak KJ, Heinze G. Whole blood viscosity, plasma viscosity and erythrocyte aggregation in nine mammalian species: reference values and comparison of data. Exp Physiol 2003; 88 (3) 431-440
    CrossrefPubMedGoogle Scholar
  • 86 Basavaraj MG, Olsen JO, Østerud B, Hansen JB. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res 2012; 130 (3) 538-546
    CrossrefPubMedGoogle Scholar
  • 87 Jayachandran M, Sanzo A, Owen WG, Miller VM. Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets. Am J Physiol Heart Circ Physiol 2005; 289 (5) H1908-H1916
    CrossrefPubMedGoogle Scholar
  • 88 Esmon CT. Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev 2009; 23 (5) 225-229
    CrossrefPubMedGoogle Scholar
  • 89 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13 (1) 34-45
    CrossrefPubMedGoogle Scholar